![4SC](../images/b4.png) ![4SC](../images/bs.png) ![4SC](../images/bc.png)
![](../images/sp.png) ![](../images/se.png) ![](../images/st.png) ![](../images/sr.png) ![](../images/sa.png) ![](../images/sn.png) ![](../images/si.png) ![](../images/sx.png) ![](../images/sspace.png) ![](../images/sa.png) ![](../images/sg.png) Annual Report
Highlights: View Competition Class Performance
Company/Agency Name: |
4SC / PETRANIX AG |
Annual Revenue: |
Up to $10 million |
Employee Base: |
Up to 100 Employees |
Core Industry: |
Biotechnology |
Type of Report: |
Annual Report |
Title/Theme: |
"Tailored drugs for strong patient benefit." |
Regional Top 50 Rank: |
44 (Europe/Middle East/Africa Region) |
Industry Award Garnered: |
Gold |
Top 100 Rank: |
94 |
|
|
Judging Results |
First Impression: |
|
Report Cover: |
|
Letter to Shareholders: |
|
Report Narrative: |
|
Report Financials: |
|
Creativity: |
|
Message Clarity: |
|
Information Accessibility: |
|
Total Score: |
|
|
![4SC](images/x9325a.jpg)
|